Document is current
Any future updates will be listed below
-
Authors
Zerella, Maria Alessia https://orcid.org/0000-0002-0992-9022
Zaffaroni, Mattia
Ronci, Giuseppe https://orcid.org/0009-0008-6795-1181
Dicuonzo, Samantha
Rojas, Damaris Patricia
Morra, Anna
Gerardi, Marianna Alessandra
Fodor, Cristiana
Rondi, Elena
Vigorito, Sabrina
Penco, Silvia
Sargenti, Manuela
Baratella, Paola
Vicini, Elisa https://orcid.org/0000-0002-7886-6758
Morigi, Consuelo https://orcid.org/0000-0002-2800-6469
Kahler-Ribeiro-Fontana, Sabrina https://orcid.org/0000-0003-0943-7471
Galimberti, Viviana Enrica https://orcid.org/0000-0002-5036-7439
Gandini, Sara https://orcid.org/0000-0002-1348-4548
De Camilli, Elisa
Renne, Giuseppe https://orcid.org/0000-0003-4484-1832
Cattani, Federica
Veronesi, Paolo
Orecchia, Roberto
Jereczek-Fossa, Barbara Alicja https://orcid.org/0000-0001-8151-3673
Leonardi, Maria Cristina https://orcid.org/0000-0001-6529-8328
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (AIRC under IG 2019 - ID. 23118)
- License Information
-
More Information
Article History
Received: 13 March 2023
Accepted: 16 August 2023
First Online: 31 August 2023
Declarations
:
: IEO, the European Institute of Oncology, is partially supported by Institutional grants from Accuray Inc. and Ion Beam Applications (IBA). Prof. Jereczek-Fossa reports personal fees for lecturers, presentations or participation on data safety monitoring or advisory boards from ESTRO, ESO, ASCO, ROCHE, BAYER, JANSSEN, CARL ZEISS, ACCURAY, ASTELLAS, ELEKTA, IBA and ACCMED outside the submitted work. MCL received speakers fee from Accuray and SD received speakers fee from Accuray Asia (all outside the current project). All the other authors have nothing to disclose.
